RAJESH B. PAREKH - 15 Jun 2022 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc. (ELOX)

Role
Director
Signature
/s/ Sumit Aggarwal, Attorney-in-Fact for Rajesh B. Parekh
Issuer symbol
ELOX
Transactions as of
15 Jun 2022
Transactions value $
$0
Form type
4
Filing time
17 Jun 2022, 08:27:06 UTC
Previous filing
28 Oct 2021
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELOX Stock Options (Right to Buy) Award $0 +20K $0.00 20K 15 Jun 2022 Common Stock 20K $0.26 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter.
F2 The Reporting Person will assign the economic interests of this grant to Advent Life Sciences LLP. The Reporting Person is a general partner of Advent Life Sciences LLP.